Huntsman

HUN · NYSE

$8.34+$0.01 (+0.12%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $8.33

HUN analyst rating

HoldConsensus of 13 analysts over the last 12 months. 15% rate it a buy.

Strong buy0
Buy2
Hold9
Underperform1
Sell1

12-month price target · 16 analysts

Average $11.85 (+42.1% upside)

Low: $9.09
Now: $8.34
High: $16.80

Upgrades and downgrades

The latest rating actions, newest first

HUN analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
RBC Capital	Oct 13, 2026	Maintains	Sector Perform	$10.00 → $9.00	46%
Barclays	Oct 13, 2026	Initiates	Equal-Weight	$10.00	50%
Wells Fargo	Oct 6, 2026	Maintains	Equal-Weight	$11.00 → $9.00	33%
UBS	Oct 5, 2026	Maintains	Neutral	$10.00 → $9.00	49%
Jefferies	Oct 2, 2026	Maintains	Buy	$16.00 → $11.00	57%
Citigroup	Sep 30, 2026	Maintains	Neutral	$11.00 → $9.00	53%
Citigroup	Sep 15, 2026	Initiates	Neutral	$11.00	53%
Keybanc	Sep 11, 2026	Initiates	Overweight	$14.00	30%
Wells Fargo	Aug 4, 2026	Maintains	Equal-Weight	$14.00 → $11.00	33%
UBS	Aug 3, 2026	Maintains	Neutral	$11.00 → $10.00	49%

The case for and against

Updated Jan 19, 2026

Bull case

Huntsman Corporation is positioned for year-over-year earnings improvement in 2026 due to the anticipated benefits from new capacity and strategic cost actions, leveraging its high operating leverage. With approximately 75% of its MDI business being differentiated and more inelastic, Huntsman may experience margin growth opportunities contingent upon recovery in the construction and automotive sectors. Furthermore, potential successful bolt-on mergers and acquisitions, coupled with better-than-expected growth from its downstream Polyurethanes business, could enhance the company's financial outlook significantly.

Bear case

Huntsman Corporation is facing significant challenges, as evidenced by downward revisions in their EBITDA estimates for Q3, FY25, and FY26, now projected at $70 million, $270 million, and $345 million, respectively. The company is experiencing persistent weakness in both price and volume across all segments, largely due to an oversupply in global polyurethanes and methyl diphenyl diisocyanate (MDI) markets, coupled with the impact of tariffs. Additionally, the influx of Asian products into South America has further weakened Huntsman's position, indicating a continued adverse supply/demand imbalance that may lead to a lower revenue run-rate in the forthcoming periods.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.